Pfiz­er and BioN­Tech hit back against Cure­Vac suit over Covid-19 vac­cine patents

Af­ter its Covid-19 vac­cine can­di­date pe­tered out, Cure­Vac ear­li­er this month filed suit against BioN­Tech in Ger­man court, stat­ing that Cure­Vac should be com­pen­sat­ed for the al­leged in­fringe­ment of a range of patents.

How­ev­er, BioN­Tech made clear that it is will­ing to go to the mat against Cure­Vac, and it brought on its part­ner Pfiz­er in a Mass­a­chu­setts court fil­ing to counter what they see as ground­less claims.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER